The Neuroscientist

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Click here to sign up for SAGE Journal Email Alerts today!

Sign In to gain access to subscriptions and/or personal tools.
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gassen, G. V.
Right arrow Articles by Annaert, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gassen, G. V.
Right arrow Articles by Annaert, W.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
The Neuroscientist, Vol. 9, No. 2, 117-126 (2003)
DOI: 10.1177/1073858403252227

Amyloid, Presenilins, and Alzheimer’s Disease

Geert Van Gassen

Wim Annaert

The regulated intramembrane proteolysis of the amyloid precursor protein (APP) that results in the generation of a toxic 40 to 42 amino acid fragment, Aß, and a C-terminal intracellular fragment stands central in the pathogenesis of Alzheimer’s disease. The fibrillar Aß peptide is extracellularly deposited in plaques in the amygdala, the hippocampus, and the neocortex of affected individuals. The APP intracellular fragment binds to transcription factors and is translocated to the nucleus, where it influences transcription. Regulated intramembrane proteolysis of APP is dependent on the activity of a multimeric protein complex of which the essential components are presenilin, nicastrin, PEN-2, and APH-1. Further research into this emerging field of presenilin-dependent APP proteolysis within the plane of the membrane might reveal the necessity of an additional transport step—bringing substrate and enzyme together—before APP can actually be processed. NEUROSCIENTIST 9(2): 117–126, 2003.

Key Words: Presenilins • Alzheimer’s disease • Amyloid beta • Regulated intramembrane proteolysis • {gamma}-secretase


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 Am. J. Physiol. Cell Physiol.Home page
Y. S. Oh and R. J. Turner
Effect of {gamma}-secretase inhibitors on muscarinic receptor-mediated calcium signaling in human salivary epithelial cells
Am J Physiol Cell Physiol, July 1, 2006; 291(1): C76 - C82.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Cell Physiol.Home page
Y. S. Oh and R. J. Turner
Evidence that the COOH terminus of human presenilin 1 is located in extracytoplasmic space
Am J Physiol Cell Physiol, September 1, 2005; 289(3): C576 - C581.
[Abstract] [Full Text] [PDF]

Home page
 ScienceHome page
D. A. Hinds, L. L. Stuve, G. B. Nilsen, E. Halperin, E. Eskin, D. G. Ballinger, K. A. Frazer, and D. R. Cox
Whole-Genome Patterns of Common DNA Variation in Three Human Populations
Science, February 18, 2005; 307(5712): 1072 - 1079.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
K. Mirnics, Z. Korade, D. Arion, O. Lazarov, T. Unger, M. Macioce, M. Sabatini, D. Terrano, K. C. Douglass, N. F. Schor, et al.
Presenilin-1-Dependent Transcriptome Changes
J. Neurosci., February 9, 2005; 25(6): 1571 - 1578.
[Abstract] [Full Text] [PDF]